Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer. - Wikidata - wikimedia - TriplyDB

Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer.

Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer.

http://www.wikidata.org/entity/Q37022652

about

Cancer prevention with promising natural products: mechanisms of action and molecular targets A Unique Cellular and Molecular Microenvironment Is Present in Tertiary Lymphoid Organs of Patients with Spontaneous Prostate Cancer Regression.Withania somnifera targets interleukin-8 and cyclooxygenase-2 in human prostate cancer progression.Serum levels of arachidonic acid metabolites change during prostate cancer progression.Part 2: pharmacogenetic variability in drug transport and phase I anticancer drug metabolism.Chemoprevention in gastrointestinal physiology and disease. Targeting the progression of cancer with natural products: a focus on gastrointestinal cancer.G protein-coupled receptor connectivity to NF-kappaB in inflammation and cancer.Green tea polyphenols for prostate cancer chemoprevention: a translational perspective Roles of Eicosanoids in Prostate Cancer.Soy isoflavones and prostate cancer: a review of molecular mechanisms.Cyclooxygenase-2 expression in animal cancers.Precursors of prostate cancer.Systematic review and meta-analysis of COX-2 expression and polymorphisms in prostate cancer.The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer Autophagy activated by the c-Jun N-terminal kinase-mediated pathway protects human prostate cancer PC3 cells from celecoxib-induced apoptosis Potent anti-cancer effects of citrus peel flavonoids in human prostate xenograft tumors.Zoledronic Acid Elicits Proinflammatory Cytokine Profile in Osteolytic Prostate Cancer Cells

P2860

Q27006530-41D1A55E-C382-435E-9552-388C062DB34B Q33694988-4492341E-4C2C-4E62-92E6-60083CE4595D Q33739134-B140178F-123A-4D50-9B5E-0659308F21D6 Q34398467-CBAF34A6-9A18-407C-80F1-24EEB6D16624 Q35584977-ACE8C6A8-567D-4D45-AE5E-8266C1876A6D Q35928052-9BD2862E-FFCB-4330-81CB-3F69F529B9F3 Q37293340-B0619EEB-08F5-4F78-AD82-FDA9330901A0 Q37461384-DCCBF6EC-7CA0-417B-8953-D50514EDC50A Q37592857-66B25BE3-6498-4F9D-966C-081BD79F7C73 Q37654590-C4C73821-8538-4D20-98D5-6586BEE22FA5 Q37793667-55BD2E77-016E-48B9-944E-FBE6D546C147 Q37972697-DBD66BF8-F4F3-47D9-ABAA-B2C322FC731F Q38051084-4A17E106-CF60-4C39-84DF-CD1D253D5933 Q38176621-03773427-511D-410C-9CC9-A67114E3AB66 Q38701724-5FFB2255-EE2B-4484-97DD-D50FBA40C1D3 Q39152132-3016E20A-146F-4E33-848B-4C93B244F639 Q59047122-7D0D21C5-3A1B-4886-B40F-4D15C73805BF

P2860

Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer.

http://www.wikidata.org/entity/Q37022652

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer.

@en

type

label

Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer.

@en

prefLabel

Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer.

@en

P1433

Q37022652-F8FFFFE7-D809-450D-9CB8-32ABF37F6CD6

P1476

Q37022652-B4A24555-2DEF-4139-8A5C-FB0AF59B5D21

P2093

Q37022652-0632A640-641E-4812-B187-BC33BA3F0431

Q37022652-1E4EB612-FEED-4635-8A39-54E66B8B162D

Q37022652-90A3855B-C085-43A7-AA54-E32DE724DBBF

Q37022652-A64C5205-2682-45F5-A6EE-004B8ADEF129

Q37022652-AC1ECFFA-03F4-403B-883D-6BBDD4EBC0F7

Q37022652-FB4427EB-75BD-42D7-9985-D3562E9CBBE7

P2860

Q37022652-04CA3723-A6E2-4A31-A21F-1B4E7632B0B4

Q37022652-132A9E4E-D3BC-41A4-944D-36C16D5C00F2

Q37022652-32426E17-42BB-4095-98D6-5DE1574484A3

Q37022652-A4F4F399-2E06-4326-901B-3CDB3DFAD9F1

Q37022652-CD2ADCAE-88F9-489F-B5D1-320BED597FA1

P2888

Q37022652-94E0620E-E256-40B5-9068-3FD6B92E1530

P304

Q37022652-E8C43077-5A07-4E98-B12A-BDD462A36FF8

P31

Q37022652-6947F8F5-27FC-49F1-95FD-9E83BC8AB87F

P356

Q37022652-BBE6947B-C1C3-44D7-90B1-204995DFDB04

P433

Q37022652-C6298BE1-E7D9-41DB-8B93-856F0C3A61DD

P478

Q37022652-1F1C7B47-EB33-497C-BB39-6D50E8117920

P577

Q37022652-E6A9D491-D301-4E3D-9CB0-3D3C50D75CAF

P5875

Q37022652-546776F3-F196-411A-BAD5-D5E37C00C2A9

P698

Q37022652-ECE72129-167B-4DC2-8D8F-3AD14F892540

P356

S12094-007-0126-0

P1433

Clinical and Translational Oncology

P1476

Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer.

@en

P2093

Antón Aparicio LM

http://www.w3.org/2001/XMLSchema#string

Aparicio Gallego G

http://www.w3.org/2001/XMLSchema#string

Cassinello Espinosa J

http://www.w3.org/2001/XMLSchema#string

Díaz Prado S

http://www.w3.org/2001/XMLSchema#string

García Campelo R

http://www.w3.org/2001/XMLSchema#string

Jiménez Fonseca P

http://www.w3.org/2001/XMLSchema#string

P2860

The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks

Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents.

Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells.

P2888

s12094-007-0126-0

P304

694-702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12094-007-0126-0

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5793456

http://www.w3.org/2001/XMLSchema#string

P698

18055324

http://www.w3.org/2001/XMLSchema#string